Question from Deputy Ken O'Flynn - PQ 36533-26
Deputy O'Flynn asked if a risk assessment has been undertaken regarding the absence of national audit and monitoring systems in certain healthcare pathways.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked if a risk assessment has been undertaken regarding the absence of national audit and monitoring systems in certain healthcare pathways.
Deputy O'Flynn asked about the number of medicines currently awaiting a commercial proposal from a marketing authorisation holder.
Deputy O'Flynn asked if obesity-related disease expenditure is identifiable within the HSE budgeting process. Read the HSE response.
Deputy O'Flynn asked if the HSE maintains any internal monitoring system tracking delays attributable to marketing authorisation holders. Read the HSE response.
Deputy O'Flynn asked about the long-term projected financial exposure associated with gender-related referrals abroad. Read the HSE response.
Deputy Collins asked about the expenditure on training of healthcare workers with regard to abortion. Read the HSE response.
Deputy O'Flynn asked if a value-for-money review has been carried out on the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked about reimbursement thresholds for applications under the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Connor asked about the number of consultant rheumatologists at Cork University Hospital and South Infirmary Victoria University Hospital.
A meeting of the HSE Audit & Risk Committee was held on Friday 15th May 2026 at 09:00am, via videoconference.